Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-Restricted T cells

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 285-291

  Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

DNA vaccination; Hepatitis B virus; Murine CTL; Virus like particles

Indexed keywords

GAMMA INTERFERON; H2 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; PLASMID DNA;

CYTOTOXIC T LYMPHOCYTE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS; MURINAE;

EID: 0033048367     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.039     Document Type: Review

References (90)

1. d with β2 microglobulin and peptide. Proc. Natl. Acad. Sci. USA 94, 6880-6885.
2. Bevan, M.J. (1976a). Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288.
3. Bevan, M.J. (1976b). Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117, 2233-2238.
4. Bhardwaj, N., Bender, A., Gonzalez, N., Bui, L.K., Garrett, M.C., and Steinman, R.M. (1994). Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94, 797-807.
5. + CTL responses in vitro. J. Clin. Invest. 98, 715-722.
6. Boog, C.J.P., Boes, J., and Melief, C.J.M. (1988). Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses. Eur. J. Immunol. 18, 219-223.
7. Böhm, W., Kuhröber, A., Paier, T., Mertens, T., Reimann, J., and Schirmbeck, R. (1996). DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocytes and antibody responses in mice after intramuscular injection. J. Immunol. Methods 193, 29-40.
8. Böhm, W., Schirmbeck, R., Elbe, A., Melber, K., Diminsky, D., Kraal, G., Van Rooijen, N., Barenholz, Y., and Reimann, J. (1995). Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155, 3313-3321.
9. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., and Falo, L.D., Jr. (1996). Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
10. Chow, Y.H., Huang, W.L., Chi, W.K., Chu, Y.D., and Tao, M.H. (1997). Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71, 169-178.
11. Corr, M., Lee, D. J., Carson, D.A., and Tighe, H. (1996). Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555-1560.
12. Davis, H.L., Schirmbeck, R., Reimann, J., and Whalen, R.G. (1995). DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 6, 1447-1456.
13. De Bruijn, M.L., Nieland, J.D., Schumacher, T.N., Ploegh, H.L., Kast, W.M., and Melief, C.J.M. (1992). Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur. J. Immunol. 22, 3013-3020.
14. Debrick, J.E., Campbell, P.A., and Staerz, U.D. (1991). Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147, 2846-2851.
15. Demi, L., Schirmbeck, R., Reimann, J., Wolf, H., and Wagner, R. (1997). Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Virology 235, 26-39.
16. Diminsky, D., Schirmbeck, R., Reimann, J., and Barenholz, Y. (1997). Comparison between surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 15, 637-647.
17. Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C.M. (1996). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578-8583.
18. Donnelly, J.J., Ulmer, J.B., Shiver, J.W., and Liu, M.A. (1997). DNA vaccines. Annu. Rev. Immunol. 15, 617-648.
19. Elbe, A., Schleischitz, S., Strunk, D., and Stingl, G. (1994). Fetal skin-derived MHC class I+, MHC class II-dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells. J. Immunol. 153, 2878-2889.
20. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., and Moser, M. (1994). Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24, 605-610.
21. Geissler, M., Gesien, A., Tokushige, K., and Wands, J.R. (1997). Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158, 1231-1237.
22. Gooding, L., and Edwards, C.B. (1980). H-2 antigen requirements in the in vitro induction of SV0-specific cytotoxic T lymphocytes. J. Immunol. 124, 1258-1262.
23. Griffiths, J.C., Harris, S.J., Layton, G.T., Berrie, E.L., French, T.J., Burns, N.R., Adams, S.E., and Kingsman, A.J. (1993). Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 67, 3191-3198.
24. d with disparate β2-microglobulin associations suggests that β2m facilitates the folding af the α1 and α2 domains during de novo synthesis. J. Immunol. 140, 3522-3527.
25. Harding, C.V. (1996). Class I MHC presentation of exogenous antigens. J. Clin. Immunol. 16, 90-96.
26. Harding, C.V., and Song, R. (1994). Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153, 4925-4933.
27. Huang, A.Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H.I. (1994). Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961-965.
28. Huang, A.Y., Bruce, A.T., Pardoll, D.M., and Levitsky, H.I. (1996a). Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183, 769-776.
29. Huang, A.Y., Bruce, A.T., Pardoll, D.M., and Levitsky, H.I. (1996b). In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4, 349-355.
30. Jondal, M., Schirmbeck, R., and Reimann, J. (1996). MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
31. Kim, J.J., Ayyavoo, V., Bagarazzi, M.L., Chattergoon, M.A., Dang, K., Wang, B., Boyer, J.D., and Weiner, D.B. (1997a). In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816-826.
32. Kim, T.S., DeKruyff, R.H., Rupper, R., Maecker, H.T., Levy, S., and Umetsu, DT. (1997b). An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol. 158, 4137-4144.
33. Krieg, A.M. (1996). An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128, 128-133.
34. b mice. J. Immunol. 156, 3687-3695.
35. Kuhröber, A., Wild, J., Pudollek, H.P., Chisari, F.V., and Reimann, J. (1997). DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int. Immunol. 9, 1203-1212.
36. Kurts, C., Heath, W.R., Carbone, F.R., Allison, J.P., Miller, J.F.A.P., and Kosaka, H. (1996). Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930.
37. Kurts, C., Carbone, F.R., Barnden, M., Blanas, E., Allison, J., Heath, W.R., and Miller, J.F. (1997a). CD4+ T cell help impairs CDS+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186, 2057-2062.
38. + T cells. J. Exp. Med. 186, 239-245.
39. Layton, G.T., Harris, S.J., Gearing, A.J., Hill Perkins, M., Cole, J.S., Griffiths, J.C., Burns, N.R., Kingsman, A.J., and Adams, S.E. (1993). Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 157, 1097-1107.
40. d class I MHC molecule. Nature 344, 439-441.
41. d class I major histocompatibility complex molecules determines their antigenic structure. J. Exp. Med. 173, 449-459.
42. Liu, T., Zhou, X., Orvell, C., Lederer, E., Ljunggren, H.-G., and Jondal, M. (1995). Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 154, 3147-3155.
43. Macatonia, S.E., Taylor, P.M., Knight, S.D., and Askonas, B.A. (1989). Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169, 1255-1264.
44. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., and Vile, R.G. (1998). Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med. 4, 581-587.
45. Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C.A., Palmiter, R.D., Brinster, R.L., Kanagawa, O., and Chisari, F.V. (1990). Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248, 361-365.
46. d induced by β2 microglobulin is fixed during de novo synthesis and irreversible by exchange or dissociation. J. Immunol. 143, 2751-2758.
47. Nair, S., Zhou, F., Reddy, R., Huang, L., and Rouse, B.T. (1992). Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175, 609-612.
48. Nair, S., Babu, J.S., Dunham, R.G., Kanda, P., Burke, R.L., and Rouse, B.T. (1993). Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J. Virol. 67, 4062-4069.
49. Nair, S., Buiting, A.M.J., Rouse, R.J., Van Rooijen, N., Huang, L., and Rouse, B.T. (1995). Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 4, 679-688.
50. Nicolet, C.M., Burkholder, J.K., Gan, J., Culp, J., Kashmiri, S.V., Schlom, J., Yang, N.S., and Sondel, P.M. (1995). Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery. Cancer Gene Ther. 2, 161-170.
51. Nonacs, R., Humborg, C., Tam, J.P., and Steinman, R.M. (1992). Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176, 519-529.
52. Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., Fukushima, J., Miyazaki, J., Wahren, B., and Okuda, K. (1997). Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159, 3638-3647.
53. Pardoll, D.M., and Beckerleg, A.M. (1995). Exposing the immunology of naked DNA vaccines. Immunity 3, 165-169.
54. Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J., and Harding, C.V. (1993). Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359-362.
55. Pisetsky, D.S. (1996a). Immune activation by bacterial DNA: a new genetic code. Immunity 5, 303-310.
56. Pisetsky, D.S. (1996b). The immunologic properties of DNA. J. Immunol. 156, 421-423.
57. Porgador, A., and Gilboa, E. (1995). Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255-260.
58. Pulaski, B.A., Yen, K.Y., Shastri, N., Maltby, K.M., Penney, D.P., Lord, E.M., and Frelinger, J.G. (1996). Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl. Acad. Sci. USA 93, 3669-3674.
59. Rakhmilevich, A.L., Turner, J., Ford, M.J., McCabe, D., Sun, W.H., Sondel, P.M., Grota, K., and Yang, N.S. (1996). Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad. Sci. USA 93, 6291-6296.
60. Raposo, G., Nijman, H.W., Stoorvogel, W., Leijendekker, R., Harding, C.V., Melief, C.J.M., Geuze, H.J., and Liejendekker, R. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172.
61. Reddehase, M.J., Keil, G.M., and Koszinowski, U.H. (1984a).The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J. Immunol. 132, 482-489.
62. Reddehase, M.J., Keil, G.M., and Koszinowski, U.H. (1984b). The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur. J. Immunol. 14, 56-61.
63. Reddy, R., Zhou, F, Nair, S., Huang, L., and Rouse, B.T. (1992). In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 148, 1585-1589.
64. Reimann, J., and Kaufmann, S.H.E. (1997). Alternate antigen processing pathways for the MHC-I-restricted epitope presentation operate for activating protective T cell immunity. Curr. Opin. Immunol. 9, 462-466.
65. Rock, K.L., Rothstein, L., Gamble, S., and Fleischacker, C. (1993). Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150, 438-446.
66. d molecules capture peptides from endocytosed, exogenous antigens for MHC class I-restricted presentation. Eur. J. Immunol. 26, 2812-2821.
67. Schirmbeck, R., Melber, K., Kuhröber, A., Janowicz, Z.A., and Reimann, J. (1994a). Immunization with soluble hepatitis B virus surface (S) protein particles elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J. Immunol. 152, 1110-1119.
68. Schirmbeck, R., Melber, K., Mertens, T., and Reimann, J. (1994b). Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J. Virol. 68, 1418-1425.
69. Schirmbeck, R., Melber, K., Mertens, T., and Reimann, J. (1994c). Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 24, 1088-1096.
70. Schirmbeck, R., Böhm, W., Ando, K.-I., Chisari, F.V., and Reimann, J. (1995a). Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69, 5929-5934.
71. Schirmbeck, R., Böhm, W., Melber, K., and Reimann, J. (1995b). Processing of exogenous heat-aggregated (denatured) or particulate(native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155, 4676-4684.
72. Schirmbeck, R., Demi, L., Melber, K., Wolf, H., Wagner, R., and Reimann, J. (1995c). Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13, 857-865.
73. Schirmbeck, R., Melber, K., and Reimann, J. (1995d). Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation. Eur. J. Immunol. 25, 1063-1070.
74. d mice that reject syngeneic tumors. J. Immunol. 157, 3550-3558.
75. d-restricted epitope presentation depends on exogenous β2m. Eur. J. Immunol. 27, 3471-3484.
76. Schirmbeck, R., Wild, J., and Reimann, J. (1998). Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B surface antigen. Eur. J. Immunol. 23, 4149-4161.
77. Sedlik, C., Saron, M.-F., Sarraseca, J., and Leclerc, C. (1997). Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 94, 7503-7508.
78. Smith, J.D., Lie, W.-R., Gorka, J., Kindle, C.S., Myers, N.B., and Hansen, T.H. (1992). Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface. J. Exp. Med. 175, 191-202.
79. d molecules at the cell surface. J. Exp. Med. 178, 2035-2046.
80. d serologic recognition. J. Immunol. 151, 5387-5397.
81. Solheim, J.C., Carreno, B.M., Myers, N.B., Lee, D.R., and Hansen, T.H. (1995a). Peptide-induced rescue of serologic epitopes on class I MHC molecules. J. Immunol. 154, 1188-1197.
82. Solheim, J.C., Johnson, N.A., Carreno, B.M., Lie, W.-R., and Hansen, T.H. (1995b). β2-microglobulin with an endoplasmic reticulum retention signal increases the surface expression of folded class I major histocompatibility complex molecules. Eur. J. Immunol. 25, 3011-3016.
83. Takahashi, H., Nakagawa, Y., Yokomuro, K., and Berzofsky, J.A. (1993). Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 5, 849-857.
84. Tan, J., Newton, CA, Djeu, J.Y. Gutsch, D.E., Chang, A.E., Yang, N.S., Klein, T.W., and Hua, Y. (1996). Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56, 3399-3403.
85. Ulmer, J.B., Deck, R.R., DeWitt, C.M., Donnhly, J.I., and Liu, M.A. (1996). Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-musclecells. Immunology 89, 59-67.
86. Xiang, Z.Q., and Ertl, H.C.J. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmidsexpressing cytokines. Immunity 2, 129-135.
87. Young, J.W., and Steinman, R.M. (1990). Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J. Exp. Med. 177, 1315-1332.
88. Zhou, F., Rouse, B.T., and Huang, L. (1992). Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J. Immunol. 149, 1599-1604.
89. Zhou, X., Berglund, P., Zhao, H., Liljestrom, P., and Jondal, M. (1995). Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc. Natl. Acad. Sci. USA 92, 3009-3013.
90. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi Castagnoli, P., Raposo, G., and Amigorena, S. (1998). Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med. 4, 594-600.